Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel
Endocannabinoids are ligands of cannabinoid receptors and a promising target for pain management. Here, the authors report a class of lipids formed by the epoxidation of N-arachidonoyl dopamine and N-arachidonoyl serotonin by cytochrome P450 epoxygenases, which reciprocally regulate canabinoid recep...
Main Authors: | William R. Arnold, Lauren N. Carnevale, Zili Xie, Javier L. Baylon, Emad Tajkhorshid, Hongzhen Hu, Aditi Das |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-20946-6 |
Similar Items
-
Cannabinoids, Endocannabinoids and Sleep
by: Andrew J. Kesner, et al.
Published: (2020-07-01) -
The Endocannabinoid System, Cannabinoids, and Pain
by: Perry G. Fine, et al.
Published: (2013-10-01) -
Cannabinoids and Endocannabinoids in mood regulation
by: Bambico, Francis
Published: (2010) -
Impact of cannabis, cannabinoids and endocannabinoids in the lungs
by: Caroline Turcotte, et al.
Published: (2016-09-01) -
The role of cannabinoids and endocannabinoid system in the treatment of epilepsy
by: Pędracka Monika, et al.
Published: (2015-12-01)